Overview
Bürkert provides fluid control systems, designing and manufacturing devices that regulate liquids and gases, from solenoid valves to complete sensor-enabled systems. Its products work by precisely actuating valves and using smart control—combining mechanical parts with electronics, sensors, and software to monitor flow, pressure, and temperature. The company stands out through its long-standing, family-owned independence, a dedicated focus on industrial fluid control, and growth via internal R&D plus selective acquisitions like ReseaTech and Green Elephant Biotech. Its goal is to keep leading the field in reliable, integrated fluid-control solutions while expanding capabilities as a privately held company.
Work here?Claim your company
Simplify's take
What believers are saying
- Gerabronn's 2026 opening expands coil production, directly supporting higher solenoid-valve throughput.
- Green Elephant Biotech partnership and Archimedes One target pharma automation and personalized medicine markets in 2026.
- Geothermal conversion and modernized facilities cut energy use, improving margins and employer brand simultaneously.
What critics are saying
- Bürkert remains heavily exposed to valve-component demand; Gerabronn is a critical concentration point.
- Its family-owned structure limits market discipline; missteps could compound across acquisitions and plant bets.
- A severe industrial downturn or Chinese valve rivals squeezing margins can erase growth and threaten independence.
What makes Bürkert unique
- Bürkert still dominates solenoid valves, now reinforced by €36 million Gerabronn capacity expansion in 2026.
- Its 2026 product upgrades, including Types 8682 and 8683, deepen hygienic automation differentiation.
- Bürkert integrates fluidics, testing, and calibration through BDG and EP Ehrler, broadening lifecycle control.
Help us improve and share your feedback! Did you find this helpful?